Response to: Correspondence on "Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab" by Gao .
Journal for immunotherapy of cancer
| Authors | |
| Keywords | |
| Year of Publication | 2025
|
| Journal | Journal for immunotherapy of cancer
|
| Volume | 13
|
| Issue | 6
|
| Date Published | 06/2025
|
| ISSN | 2051-1426
|
| DOI | 10.1136/jitc-2025-012742
|
| PubMed ID | 40537242
|
| Links |